According to the latest report by Renub Research, the United States Home Infusion Therapy Market is projected to grow from USD 10.26 billion in 2024 to USD 20.59 billion by 2033, expanding at a CAGR of 8.05% during 2025–2033. This robust growth is driven by the rising prevalence of chronic diseases, growing demand for cost-effective healthcare, and significant advancements in home healthcare technology. Increasing patient preference for home-based care due to convenience, safety, and affordability is reshaping the U.S. healthcare landscape.
Growing Adoption of Home Infusion Therapy
Home infusion therapy involves the administration of medications, nutrients, or fluids via intravenous (IV) or subcutaneous routes in the comfort of a patient’s home. This approach eliminates the need for prolonged hospital stays, thereby reducing medical costs and the risk of hospital-acquired infections.
The market’s growth is further supported by enhanced infusion devices, remote patient monitoring, and